EperisoneEperisone hydrochloride
MedChemExpress (MCE)
HY-B1901
56839-43-1
盐酸乙哌立松
盐酸乙哌立松
(±-Eperisone hydrochloride
99.95%
4°C,密封保存,远离潮湿 *溶剂中:-80°C,6个月;-20°C,1个月(密封保存,远离潮湿)
美国大陆的室温;其他地方可能有所不同。
Eperisone Hydrochloride ((±)-Eperisone hydrochloride) 是具有口服活性的抗痉挛试剂 (antispastic agent),具有扩血管作用,主要用于研究肌肉僵硬和疼痛。Eperisone Hydrochloride 是一种强效的选择性 P2X7 receptor 拮抗剂,对人 P2X3 也有弱拮抗作用。Eperisone Hydrochloride 通过放松骨骼肌和血管平滑肌起多种作用,例如减少肌张力,改善循环和抑制疼痛反射。
Eperisone Hydrochloride ((±)-Eperisone hydrochloride) 是一种抗痉挛剂,用于治疗以肌肉僵硬和疼痛为特征的疾病。它通过放松骨骼肌和血管平滑肌起作用,从而显示出多种作用,例如减少肌强直、改善循环和抑制疼痛反射。 Eperisone Hydrochloride ((±)-Eperisone hydrochloride) 是一种中枢性肌肉松弛剂,抑制疼痛反射通路,具有血管扩张作用[1][2 [3 ]。
Eperisone Hydrochloride (0-200 µM, 18-72 小时) 在体外优先抑制肺成纤维细胞活性,但对肺泡上皮细胞没有毒性[5]。 MCE尚未独立证实这些方法的准确性。仅供参考。
Eperisone Hydrochloride (15 或 50 mg/kg, 口服, 单次给药, 连用 9 天) 通过抑制小鼠肺部成纤维细胞活化来抑制 Bleomycin (BLM) (HY-108345) 依赖的肺纤维化[5]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| | | |
| | | | | |
[1]. Cabitza P, et al. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study. Eur Rev Med Pharmacol Sci. 2008 Jul-Aug
12(4):229-35.
[2]. Frandisco Colomer Rusinvol, et al. Effects of Two Diffferent Doses of Eperisone in the Treatment of Acute Low Back Pain. The Journal of Applied Research.
[3]. Bavage S, et al. Clinical efficacy and safety of eperisone for low back pain: A systematic literature review. Pharmacol Rep. 2016 Oct
68(5):903-12.
[4]. Park KH, Lee SC, Yuk JE, Kim SR, Lee JH, Park JW. Eperisone-Induced Anaphylaxis: Pharmacovigilance Data and Results of Allergy Testing. Allergy Asthma Immunol Res. 2019
11(2):231-240.
[5]. Tanaka KI, et al. Therapeutic effects of eperisone on pulmonary fibrosis via preferential suppression of fibroblast activity. Cell Death Discov. 2022 Feb 8
8(1):52.
[6]. Okada M, et al. Eperisone Hydrochloride, a Muscle Relaxant, Is a Potent P2X7 Receptor Antagonist. Chem Pharm Bull (Tokyo). 2024
72(3):345-348.